🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate efficacy and of safety QL0911 in t...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-04-20
Trial ID
NCT07455006
To evaluate the efficacy and safety of QL0911 in Chemotherapy- Induced Thro...
Status
Completed
Location
Shanghai East Hospital
Start Date
2021-01-15
Trial ID
NCT05851027
Treatments Being Tested
To evaluate the efficacy and safety of QL0911 to prevention chemotherapy-in...
Status
Completed
Location
Shanghai East Hospital
Start Date
2022-11-08
Trial ID
NCT05554913
To evaluate the efficacy and safety of QL0911 in cancer treatment-induced t...
Status
Recruiting
Location
Harbin First Hospital
Start Date
2024-10-22
Trial ID
NCT06456528
Treatments Being Tested
QL0911, a recombinant human thrombopoietin mimetic peptide-Fc fusion protei...
Status
Completed
Location
Qilu Hospital of Shandong University
Start Date
2019-10-18
Trial ID
NCT05621330
Treatments Being Tested